PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Better regulation of mental health ‘therapies’ urgently needed to protect the vulnerable

2023-10-23
(Press-News.org) A rise in psychological pseudoscience is putting people at risk, psychologists have warned, with social media and celebrity endorsements partly to blame.

Mental health apps, mood-boosting supplements and energy therapies are among the therapies that could do ‘more harm than good’ according to psychologists Jonathan Stea and Stephen Hupp in their new book Investigating Clinical Psychology.

“As discourse around wellness, mental health, therapy, and access to these resources increasingly enter the public domain, the potential of coming across persuasive pseudoscience has also increased,” Stea explains.

“This is the age of health misinformation. It is everywhere. It is in our social media feeds, promoted by celebrities and influencers, and permeates the legacy news media. We are bombarded with advertisements pushing unsupported therapies and practices. Health misinformation has also worked its way into TV shows, movies, and books. And, increasingly, it is embraced and promoted by prominent politicians.”

Separating fact from fiction

Stea, Hupp and a slew of experts in the field have come together in a series of expert-led deep-dives into the world of clinical psychology with a focus on debunking and differentiating between pseudoscientific- and scientific approaches.

The book covers a variety of topics, including crystal healing, detoxing, animal-assisted therapies, hypnosis, and energy medicine.

“There have been many important contributions to clinical psychology that have flourished in the last century, but there has been an equally powerful but harmful rise in pseudoscience,” Hupp explains. “It is great that more people are talking about mental health – but it must be linked to scientific evidence.”

The authors and contributors give evidence to suggest pseudoscience causes direct harm – not only can it take vital time and money away from valid health provision, but it also erodes public trust in healthcare, besides having potentially detrimental effects on the patient themselves.

And the authors argue this is not a theoretical issue, as there are contemporary harmful and/or debunked therapies currently still in use – such as repressed memory practice and conversion therapy.

“If you think about this hypothetical journey, someone who is unwell may self-diagnose on social media with a condition not recognized by the medical community,” Stea says. “They may use a search engine to find out how to ‘treat’ said condition and encounter a scientifically implausible treatment.”

The book also gives historical examples of popular pseudoscientific psychology including primal scream therapy and psychoanalytical theories such as dream interpretation. It also explores the limits of popular psychological tools, like the Rorschach Inkblot Test, hypnotherapy, and the Myers-Briggs Personality Test, and questions the scientific rigor behind the eye-movement component of increasingly popular EMDR, despite considerable evidence supporting its overall efficacy.

The impact of popular culture

In the chapter supplied by Blake Boehme, Andres De Los Reyes, and Gordon Asmundson, they highlight how several professions with little or no mental health training have ‘injected themselves into the mental health landscape’.

They explain that people suffering from poorly understood or unexplained symptoms are particularly vulnerable, as they are desperate for an explanation for their condition and effective treatment.

“The symptoms and distress they experience are real and should be treated with compassion; however, compassion and exploitation should not be mistaken for one another,” they explain.

Some practitioners claim to hold knowledge about a condition that others do not and can gain a cult-like following, they suggest, gaining testimonials from supporters despite a lack of tangible evidence that the cure is accurate and effective.

“The new diagnosis becomes diagnosis du jour, often replacing or displacing the previous diagnosis, with information communications infrastructure (e.g., internet search engines) playing a crucial role in the rapidity of the spread,” they explain.

The authors describe how celebrities have publicly announced their diagnoses by practitioners who treat their conditions with unscientific methods, such as herbal remedies.

“A potent form of anecdote is now derived from celebrities or social media personalities,” they explain. “This anecdotal evidence is spread quickly by modern social media networks and can be subject to a continuous process of manipulation and revision as it spreads from person to person. An individual’s understanding of scientific principles can make them more or less likely to be manipulated by online pseudoscientific claims.”

‘Raising the bar’

To counter this rise in pseudoscience, the book suggests firmer regulation of mental health services and better-quality scientific studies into the efficacy of popular treatment. They endorse a system by which treatments cannot be offered to the public unless they meet strict criteria, including consistent results across large amounts of studies which demonstrate functional outcomes and lasting effects.

Further recommendations in the book include improving science literacy among the public and making health misinformation part of school curriculum so people know what to look out for.

The book’s editors also arm its readers with ‘signs’ of pseudoscience, including those who reverse the burden of proof on skeptics rather than proponents, an absence of connectivity to the broader scientific literature, an over-reliance on testimonials and elevation of anecdotal evidence and use of obscurantist and science-y sounding language.

Hupp concludes: “People with mental health challenges deserve the best, evidence-based therapies such as the many variations of behavioral and cognitive therapies. Looking ahead, it’s time to raise the bar.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Do people everywhere care less about their cats than their dogs?

2023-10-23
Do canines get more care? Some studies have suggested pet owners are less emotionally attached to and less willing to finance care for cats than dogs, possibly because of cats’ behavior: cats may be perceived as caring less about humans and needing less care in return. But these studies are often conducted on non-representative samples and don’t consider possible cultural differences in attitudes to pets. A team of scientists led by Dr Peter Sandøe of the University of Copenhagen decided to investigate further. “We and others have found that people are willing to spend much less on their cats than ...

Association for Molecular Pathology appoints Lauren S. Menser as Chief Executive Officer

2023-10-23
ROCKVILLE, Md. – Oct.  23, 2023 – The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today announced the appointment of Lauren S. Menser, CAE, as its Chief Executive Officer, effective January 3, 2024. Menser will succeed Mary Steele Williams, MNA, MT(ASCP)SM, CAE, after her retirement. AMP’s national search for a new executive leader was administered by an outside consulting firm and overseen by a diverse group of member volunteers. Menser has served AMP in various capacities for more than 17 years. Since 2016, she has served as Director of Strategic Development, ...

Predictors of opioid overdose after prescription for chronic pain

2023-10-23
A large study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230459 identified 10 predictors of opioid overdose after prescription for chronic pain, which can help clinicians engage in shared decision-making with patients around opioid prescribing. “The opioid crisis has generated interest in identifying patients at higher risk of addiction or overdose and has led to the development of several screening tools; however, these instruments have either not been validated or shown poor psychometric properties,” writes Dr. Li Wang, a researcher and methodologist at the ...

Plant-based isn't just about burgers anymore

Plant-based isnt just about burgers anymore
2023-10-23
A team of University of Waterloo researchers has created smart, advanced materials that will be the building blocks for a future generation of soft medical microrobots.  These tiny robots have the potential to conduct medical procedures, such as biopsy, and cell and tissue transport, in a minimally invasive fashion. They can move through confined and flooded environments, like the human body, and deliver delicate and light cargo, such as cells or tissues, to a target position. The tiny soft robots are a maximum of one centimetre long and are bio-compatible and non-toxic. The robots are made of advanced hydrogel ...

Better use of existing drugs increases cervical cancer survival and reduces recurrence

2023-10-22
The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer. As part of an analysis of clinical data, the preliminary results will be presented at the European Society for Medical Oncology (ESMO) congress on Sunday 22 October 2023. The peak incidence of cervical cancer is in women in their early thirties, with around 3,200 new cases each year in the UK. CRT has been the standard treatment for cervical cancer since 1999, but despite improvements ...

Adding immunotherapy to chemotherapy regimen improves survival in metastatic bladder cancer patients

2023-10-22
New York, NY (October 22, 2023) — A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. The results were simultaneously reported in The New England Journal of Medicine and at the annual meeting of the European Society for Medical Oncology. The randomized phase 3 trial, named ”CheckMate 901,” showed significantly improved outcomes in patients who received the immunotherapy nivolumab with a combination of the chemotherapies gemcitabine and cisplatin, ...

Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds

2023-10-22
Cabozantinib, which targets tumor cell growth and tumor blood vessel growth, sharply improved progression-free survival over placebo in patients with extra-pancreatic and pancreatic neuroendocrine tumors Boston - A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators. Jennifer Chan, MD, MPH, director of the Program ...

Alliance presents detailed results from phase III CABINET pivotal Trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2023

Alliance presents detailed results from phase III CABINET pivotal Trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2023
2023-10-22
The Alliance for Clinical Trials in Oncology today announced detailed results will be presented at ESMO 2023 from CABINET (A021602), a phase III pivotal trial evaluating cabozantinib compared with placebo in two cohorts of patients with previously treated neuroendocrine tumors: one cohort of patients with advanced pancreatic neuroendocrine tumors (pNET) and a second cohort of patients with advanced extra-pancreatic NET (epNET). The study met the primary objective for each cohort, demonstrating that cabozantinib provided dramatic improvements in median progression-free survival (PFS) for the patients in the pNET and epNET cohorts. ...

ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
2023-10-21
MADRID ― Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC). Results from the Phase III CheckMate 77T study were presented today at the 2023 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center. At a median follow-up of 25.4 months, the median EFS with chemotherapy alone was 18.4 months, while the median had not yet been reached for patients receiving perioperative nivolumab, meaning EFS was prolonged ...

Kidney cancer study shows improved outcomes for patients with advanced disease when treated with belzutifan over everolimus

2023-10-21
Boston – Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibitors and anti-angiogenic therapies compared with everolimus in a phase 3 clinical trial. The trial, led by Toni K. Choueiri, MD, Director of the Lank Center for Genitourinary Cancer at Dana-Farber Cancer Institute, showed the risk of progression was reduced by 25-26%. The results were presented at the annual European Society for Medical Oncology (ESMO) Congress on October ...

LAST 30 PRESS RELEASES:

Two thirds of reproductive-aged women have at least one modifiable risk factor for birth defects, study reveals

Boosting the neuroglia as a therapeutic strategy for brain disorders

Computational neurogenomics revolution unlocks personalized treatments for brain disorders worldwide

Psychedelics researcher reveals how MDMA and LSD transform human connectedness

Making low-fertility rats fertile by changing the treatment interval

Common painkillers linked to antibiotic resistance

Teachers' depression, anxiety and stress at three times the national norm: new study

Common cold may protect against COVID-19 according to National Jewish Health researchers

New project to improve information retrieval for lifelong learning

New method probes cancer cell messengers that weaken immune system

VCs backed Black founders after BLM – but it didn’t last

A new tool to track infant development, starting at just 16 days old

Generative AI uncovers undetected bird flu exposure risks in Maryland emergency departments

High concentration THC associated with schizophrenia, psychosis, and other unfavorable mental health outcomes

Mediterranean diet with fewer calories and exercise lowers diabetes risk by 31%

Mediterranean diet combined with calorie reduction and exercise may reduce risk of type 2 diabetes by nearly one-third

Researchers to gather next week for 10th Peer Review Congress

Rising deep-ocean oxygen levels opened up new marine habitats, spurred speciation

Melanie Cocco named as next Editor-in-Chief of Biophysical Reports

Polysubstance involvement in youth opioid overdoses increases with age

Brain’s blood flow could change how we understand and treat Alzheimer’s

Mount Sinai scientists create AI-powered tool to improve cancer tissue analysis

Scientists discover how cells use a secret weapon to fight off some pathogens

Research uncovers why IBD causes blood clots—and how to prevent them

Having a sense of purpose may protect against dementia

Trump shooting and Biden exit flipped social media from hostility to solidarity – study

New discovery of wild cereal foraging – a precursor to agriculture – far from the fertile crescent

Flamingos reveal their secret to ageing

An early sign of cognitive decline in aging populations

Neural activity linked to self-preoccupied thinking

[Press-News.org] Better regulation of mental health ‘therapies’ urgently needed to protect the vulnerable